reference/32526530

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32526530

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1121
issn	1527-7755 0732-183X
issueIdentifier	10
pageRange	1114-1121
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	1114
bibliographicCitation	Lee JS, Hirsh V, Park K, Qin S, Blajman CR, Perng RP, Chen YM, Emerson L, Langmuir P, Manegold C. Vandetanib Versus placebo in patients with advanced non-small-cell lung cancer after prior therapy with an epidermal growth factor receptor tyrosine kinase inhibitor: a randomized, double-blind phase III trial (ZEPHYR). J Clin Oncol. 2012 Apr 01;30(10):1114–21. doi: 10.1200/jco.2011.36.1709. PMID: 22370318.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_43f31bd088cef9a1da5eba1c135f24ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d6127095553bb11354ff713539cd8b6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5f7f602831a1128bbaba1d831a0ecb6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdde301f6d4dd9313e261b488686fdf7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d28712177d15dab2348ba47034f5c32 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95a4effb72d054175146aa9b33de9779 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab3085b763887a35907bad4ca3a9f1e1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b4a849344bd1bc5c7dd3a543b13770a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48486ec35e24278a08c5a2ebe1a5b8c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41f3855568922b229054144d63bd660e
date	2012-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22370318 https://doi.org/10.1200/jco.2011.36.1709
isPartOf	https://portal.issn.org/resource/ISSN/0732-183X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/1527-7755
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Vandetanib Versus Placebo in Patients With Advanced Non–Small-Cell Lung Cancer After Prior Therapy With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor: A Randomized, Double-Blind Phase III Trial (ZEPHYR)
discusses	http://id.nlm.nih.gov/mesh/M0017888 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0500817 http://id.nlm.nih.gov/mesh/M0421253 http://id.nlm.nih.gov/mesh/M0016885 http://id.nlm.nih.gov/mesh/M0018336
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010880Q000627 http://id.nlm.nih.gov/mesh/D011799Q000627 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D066246Q000037 http://id.nlm.nih.gov/mesh/D011505Q000037 http://id.nlm.nih.gov/mesh/D008175Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D002289Q000556 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D016017 http://id.nlm.nih.gov/mesh/D010880Q000009 http://id.nlm.nih.gov/mesh/D011799Q000009 http://id.nlm.nih.gov/mesh/D012907Q000009 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D066246Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081361 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247533733

Total number of triples: 73.